Broader Value Elements: Methods to Quantify Each and Their Relevance for European Markets
Author(s)
Discussion Leader: Richard Willke, PhD, Scintegral Health Economics, Lawrenceville, NJ, USA
Discussants: Jason Shafrin, PhD, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, USA; Melanie D. Whittington, PhD, MS, Tufts Medical Center (CEVR), Boston, MA, USA; Lotte Steuten, PhD, Office of Health Economics, London, LON, UK
PURPOSE:
Despite the ISPOR Value Flower being a mainstay in the health economics and outcomes research community, broader value elements are still not regularly quantified by many health technology assessment (HTA) bodies. This workshop will provide attendees with recommended best practices to quantify each value element within the ISPOR Value Flower and will then discuss their likelihood of implementation and relevance for European HTA bodies.DESCRIPTION:
Dr. Willke will introduce the workshop by briefly describing Value Flower history and the current state of play for the consideration of the broader value elements by HTA bodies in the UK, France, Germany, Spain, and the US. (9 minutes) Dr. Shafrin will then present the recommended method and associated best practices for quantifying the following ISPOR Value Flower elements: severity of disease, value of hope, value of knowing, insurance value, and fear of contagion. (12 minutes) Dr. Whittington will then present the recommended method and associated best practices for quantifying the remaining ISPOR Value Flower elements, including productivity, family spillovers, equity, real-option value, and scientific spillovers. (12 minutes) Dr. Steuten will conclude the workshop with her perspective on the likelihood that these broader value elements will be adopted by HTA bodies in the UK, France, Germany and Spain with a discussion on the applicability of the broader value elements to each HTA body’s decision making. (12 minutes). Audience Q&A (15 minutes). Polling questions will be used after the panelists’ presentations to (i) verify audience understanding of methodologies for estimating broader value elements, and (ii) assess audience opinions on the relevance of these broader value elements for European markets. Workshop attendees will receive QR code that links to an abbreviated user guide for estimating each broader value element. This workshop will be relevant for health economists, HTA bodies, manufacturers, payers, and patient advocacy organizations.Conference/Value in Health Info
2024-11, ISPOR Europe 2024, Barcelona, Spain
Code
148
Topic
Economic Evaluation